For citations:
Erdes Sh.F. INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS. Rheumatology Science and Practice. 2016;54(1S):60-66. (In Russ.) https://doi.org/10.14412/1995-4484-2016-1S-60-66
Erdes Sh.F. INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS. Rheumatology Science and Practice. 2016;54(1S):60-66. (In Russ.) https://doi.org/10.14412/1995-4484-2016-1S-60-66